Search Results 241-250 of 11912 for Valerian Root
Dr. Dietz joined Mayo Clinic in 1996 and has been a driving force behind the research into medical treatments using cell-based technologies, including adult- ...
Latest stories. Addressing the root cause of rare diseases — the promise of antisense oligonucleotides featured image. Individualized Medicine.
This study is a Phase III, randomised, open label, multi-centre study assessing the efficacy and safety of MEDI4736 versus Standard of Care in NSCLC ...
Learn about this rare cancer that forms on the skin that surrounds the urethra and vagina. Treatments include surgery, radiation and chemotherapy.
Addressing the root cause of rare diseases — the promise of antisense oligonucleotides featured image. Individualized Medicine. Addressing the root cause ...
The purpose of this study is to investigate the effectiveness and safety of REC-2282 in patients with progressive NF2 mutated meningiomas who have either NF2 ...
Rochester, Minn. The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) ...
Mayo Clinic's Aging & Immune Restoration Lab led by Jessica N. Lancaster, Ph.D., visualizes T & B cells to learn how the immune system breaks down with age, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.